Bivalirudin versus Heparin on Net Adverse Clinical Events, Major Adverse Cardiac and Cerebral Events, and Bleeding in Elderly Chinese Patients Treated with Percutaneous Coronary Intervention
Tohoku J Exp Med. 2023 Oct 12. doi: 10.1620/tjem.2023.J085. Online ahead of print.NO ABSTRACTPMID:37821386 | DOI:10.1620/tjem.2023.J085 (Source: The Tohoku Journal of Experimental Medicine)
Source: The Tohoku Journal of Experimental Medicine - October 11, 2023 Category: Research Authors: Qin Li Huayun Li Zhongfei Liu Lingxiao Duan Source Type: research

Bivalirudin versus Heparin on Net Adverse Clinical Events, Major Adverse Cardiac and Cerebral Events, and Bleeding in Elderly Chinese Patients Treated with Percutaneous Coronary Intervention
Tohoku J Exp Med. 2023 Oct 12. doi: 10.1620/tjem.2023.J085. Online ahead of print.NO ABSTRACTPMID:37821386 | DOI:10.1620/tjem.2023.J085 (Source: The Tohoku Journal of Experimental Medicine)
Source: The Tohoku Journal of Experimental Medicine - October 11, 2023 Category: Research Authors: Qin Li Huayun Li Zhongfei Liu Lingxiao Duan Source Type: research

Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials
CONCLUSIONS: In patients with non-ST-segment-elevation myocardial infarction undergoing PCI, procedural anticoagulation with bivalirudin and heparin did not result in significantly different rates of mortality or ischemic events, including stent thrombosis and reinfarction. Bivalirudin reduced serious bleeding compared with heparin arising both from the access site and nonaccess sites.PMID:37746717 | DOI:10.1161/CIRCULATIONAHA.123.063946 (Source: Circulation)
Source: Circulation - September 25, 2023 Category: Cardiology Authors: Behnood Bikdeli David Erlinge Marco Valgimigli Adnan Kastrati Yaling Han Philippe Gabriel Steg Rod H Stables Roxana Mehran Stefan K James Enrico Frigoli Patrick Goldstein Yi Li Adeel Shahzad Stefanie Sch üpke Ghazaleh Mehdipoor Shmuel Chen Bj örn Redfor Source Type: research

Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials
CONCLUSIONS: In patients with non-ST-segment-elevation myocardial infarction undergoing PCI, procedural anticoagulation with bivalirudin and heparin did not result in significantly different rates of mortality or ischemic events, including stent thrombosis and reinfarction. Bivalirudin reduced serious bleeding compared with heparin arising both from the access site and nonaccess sites.PMID:37746717 | DOI:10.1161/CIRCULATIONAHA.123.063946 (Source: Circulation)
Source: Circulation - September 25, 2023 Category: Cardiology Authors: Behnood Bikdeli David Erlinge Marco Valgimigli Adnan Kastrati Yaling Han Philippe Gabriel Steg Rod H Stables Roxana Mehran Stefan K James Enrico Frigoli Patrick Goldstein Yi Li Adeel Shahzad Stefanie Sch üpke Ghazaleh Mehdipoor Shmuel Chen Bj örn Redfor Source Type: research

Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials
CONCLUSIONS: In patients with non-ST-segment-elevation myocardial infarction undergoing PCI, procedural anticoagulation with bivalirudin and heparin did not result in significantly different rates of mortality or ischemic events, including stent thrombosis and reinfarction. Bivalirudin reduced serious bleeding compared with heparin arising both from the access site and nonaccess sites.PMID:37746717 | DOI:10.1161/CIRCULATIONAHA.123.063946 (Source: Circulation)
Source: Circulation - September 25, 2023 Category: Cardiology Authors: Behnood Bikdeli David Erlinge Marco Valgimigli Adnan Kastrati Yaling Han Philippe Gabriel Steg Rod H Stables Roxana Mehran Stefan K James Enrico Frigoli Patrick Goldstein Yi Li Adeel Shahzad Stefanie Sch üpke Ghazaleh Mehdipoor Shmuel Chen Bj örn Redfor Source Type: research

Bivalirudin for cardiopulmonary bypass in a patient with heparin allergy
Hypersensitivity reactions to heparin are uncommon conditions but pose a serious clinical problem for patients requiring cardiopulmonary bypass. Bivalirudin is a reversible direct thrombin inhibitor that can b... (Source: Journal of Cardiothoracic Surgery)
Source: Journal of Cardiothoracic Surgery - September 11, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Emre Boysan, Renda Circi, Osman Fehmi Beyazal and Erol Şener Tags: Case Report Source Type: research

Anticoagulation strategies in COVID-19 infected patients receiving ECMO support
CONCLUSION: In hospitalized patients with COVID-19-associated acute respiratory distress syndrome (ARDS) on VV ECMO support, the use of bivalirudin showed to be a viable anticoagulation alternative in terms of efficacy compared to UFH and resulted in a favorable safety profile with lower rates of bleeding and thrombotic events.PMID:37682210 | DOI:10.1051/ject/2023027 (Source: Journal of Extra-Corporeal Technology)
Source: Journal of Extra-Corporeal Technology - September 8, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Dayne Diaz Jenny Martinez Grant Bushman William R Wolowich Source Type: research

Anticoagulation strategies in COVID-19 infected patients receiving ECMO support
CONCLUSION: In hospitalized patients with COVID-19-associated acute respiratory distress syndrome (ARDS) on VV ECMO support, the use of bivalirudin showed to be a viable anticoagulation alternative in terms of efficacy compared to UFH and resulted in a favorable safety profile with lower rates of bleeding and thrombotic events.PMID:37682210 | PMC:PMC10487306 | DOI:10.1051/ject/2023027 (Source: Journal of Extra-Corporeal Technology)
Source: Journal of Extra-Corporeal Technology - September 8, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Dayne Diaz Jenny Martinez Grant Bushman William R Wolowich Source Type: research